View in EDS

Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis.

Saved in:
Bibliographic Details
Title: Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis.
Authors: Bissonnette R; Innovaderm Research Inc., Montreal, Quebec, Canada. Electronic address: rbissonnette@innovaderm.com., Stein Gold L; Henry Ford Health System, Detroit, Michigan., Kircik L; Icahn School of Medicine at Mount Sinai, New York, New York., Simpson EL; Oregon Health & Science University, Portland, Oregon., Eichenfield LF; University of California San Diego and Rady Children's Hospital, San Diego, California., Browning J; Texas Dermatology and Laser Specialists, San Antonio, Texas., Hebert AA; UTHealth McGovern School of Medicine and Children's Memorial Hermann Hospital, Houston, Texas., Alexis AF; Weill Cornell Medicine, New York, New York., Soong W; AllerVie Health and Clinical Research, Birmingham, Alabama., Piscitelli SC; Formerly of Dermavant Sciences, Inc., Morrisville, North Carolina., Tallman AM; Dermavant Sciences, Inc., Morrisville, North Carolina., Rubenstein DS; Formerly of Dermavant Sciences, Inc., Morrisville, North Carolina., Brown PM; Dermavant Sciences, Inc., Morrisville, North Carolina., Silverberg JI; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2025 Sep; Vol. 93 (3), pp. 707-714. Date of Electronic Publication: 2025 May 16.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6787
DOI:10.1016/j.jaad.2025.05.1391